Gumiguru 2021: Cabozantinib (Cabometyx, Exelixis, Inc.) yakatenderwa neFood and Drug Administration yevakuru nevana varwere vane makore gumi nemaviri zvichikwira avo vane zera repamusoro kana metastatic kusiyanisa thyroi.
Lenvatinib (Lenvima) New oral anticancer drug Lenvima (lenvatinib) has recently been approved by Japan for the treatment of unresectable thyroid cancer. This is another important market that the drug has captured since it was app..